Post

Premarket Notification Requirements for Dermabrasion Devices

This guidance assists manufacturers in submitting premarket notifications (510(k)) for dermabrasion devices intended to abrade or erode skin. It covers both manual and motorized dermabrasion devices, which are Class I devices generally exempt from 510(k) requirements unless they have different intended uses or fundamental technologies.

  1. Determine if 510(k) submission is required based on intended use and technology differences from legally marketed devices
  2. If 510(k) required, prepare comprehensive device description including materials, mode of action, and output parameters
  3. Develop and validate sterilization procedures and documentation
  4. Prepare required labeling including sterilization instructions
  5. For new indications:
    • Design clinical study protocol
    • Submit protocol to FDA for review before starting clinical trials
    • Collect comparative safety and effectiveness data
  6. Compile all required documentation for 510(k) submission
  7. Ensure compliance with sterilization requirements and validation
  8. Maintain documentation of comparison with predicate device

Key Considerations

Clinical testing

  • Clinical data required only for indications other than general dermabrasion, scar revision, and tattoo removal
  • Device considered non-significant risk
  • Recommended to submit study protocol to FDA before starting clinical trials

Labelling

  • Must include predicate device labeling
  • Must include proposed device labeling
  • Must include sterilization instructions for non-sterile or reusable components

Safety

  • Sterilization information must specify:
    • Pre-sterilized components
    • Components requiring sterilization before use
    • Mode of sterilization
    • Sterility assurance level (SAL)
    • Validation method

Other considerations

  • 21 CFR 878.4800: Manual dermabrasion devices classification
  • 21 CFR 878.4820: Motorized dermabrasion devices classification
  • 21 CFR 878.9: Limitations of exemptions
  • 21 CFR 812.3(m): Significant risk device criteria

Original guidance

  • Premarket Notification Requirements for Dermabrasion Devices
  • HTML / PDF
  • Issue date: 1999-03-01
  • Last changed date: 2020-03-18
  • Status: FINAL
  • Official FDA topics: Medical Devices, Premarket
  • ReguVirta summary file ID: d3da0e828f2e089f1293f8ba29597de6
This post is licensed under CC BY 4.0 by the author.